Langerhans cells and chemical allergy

Current Opinion in Immunology

Volumn 10, Issue 6, 1998, Pages 614-619

  Kimber, Ian ^a   Dearman, Rebecca J ^a   Cumberbatch, Marie ^a   Huby, Russell Jd ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ALLERGY; CELL DEATH; CELL MATURATION; CELL MIGRATION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE; REVIEW; SKIN CELL; SKIN SENSITIZATION; T LYMPHOCYTE;

EID: 0032403696     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80078-2     Document Type: Article

References (55)

1. Kimber I, Cumberbatch M. Dendritic cells and cutaneous immune responses to chemical allergens. Toxicol Appl Pharmacol. 117:1992;137-146.
2. Kimber I, Dearman RJ. Cell and molecular biology of chemical allergy. Clin Rev Allergy Immunol. 15:1997;145-168.
3. Streilein JW, Grammer SF. In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes. J Immunol. 143:1989;3925-3933.
4. Heufler C, Koch F, Schuler G. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of epidermal Langerhans cells into potent immunostimulatory dendritic cells. J Exp Med. 167:1988;700-705.
5. Picut CA, Lee CS, Dougherty EP, Anderson KL, Lewis RM. Immunostimulatory capabilities of highly enriched Langerhans cells in vitro. J Invest Dermatol. 90:1988;201-206.
6. Furue M, Chang CH, Tamaki K. Interleukin-1 but not tumour necrosis factor α synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells. Brit J Dermatol. 135:1996;194-198.
7. Ozawa H, Nakagawa S, Tagami H, Aiba S. Interleukin-1β and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently. J Invest Dermatol. 106:1996;441-445.
8. Cumberbatch M, Kimber I. Dermal tumour necrosis factor-α induces dendritic cell migration to draining lymph nodes and possibly provides one stimulus for Langerhans cell migration. Immunology. 75:1992;257-263.
9. Cumberbatch M, Fielding I, Kimber I. Modulation of epidermal Langerhans cell frequency by tumour necrosis factor-α Immunology. 81:1994;395-401.
10. Cumberbatch M, Kimber I. Tumour necrosis factor-α is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitization. Immunology. 84:1995;31-35.
11. Ryffel B, Brockhaus M, Greiner B, Mihatsch MJ, Gudat F. Tumour necrosis factor receptor distribution in human lymphoid tissue. Immunology. 74:1991;446-452.
12. Larregina A, Morelli A, Kolkowski E, Fainboim L. Flow cytometric analysis of cytokine receptors on human Langerhans cells. Changes observed after short term culture. Immunology. 87:1996;317-325.
13. Wang B, Fujisawa H, Zhuang L, Kondo S, Shivji GM, Kim CS, Mak TW, Sauder DN. Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. of special interest J Immunol. 159:1997;6148-6155 This paper, together with other [8,9,11,12], provides evidence that TNF-α signalling in LCs is effected exclusively via TNFR2. LC migration was normal in mice lacking TNFR1 but was inhibited in TNFR2-deficient mice.
14. Cumberbatch M, Dearman RJ, Kimber I. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α Arch Dermatol Res. 289:1997;277-284.
15. Cumberbatch M, Dearman RJ, Kimber I. Langerhans cells require signals from both tumour necrosis factor-α and interleukin 1β for migration. of special interest Immunology. 92:1997;388-395 Together with other references [10,13], this paper provides evidence that the effective stimulation of LC migration requires two discrete signals - one provided by IL-1β, the other by TNF-α.
16. Shornick LP, De Togni P, Mariathasan S, Goellner J, Strauss-Schoenberger J, Karr RW, Ferguson TA, Chaplin DD. Mice deficient in IL-1β manifest impaired contact hypersensitivity to trinitrochlorobenzene. J Exp Med. 183:1996;1427-1436.
17. Enk AH, Katz SI. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA. 89:1992;1398-1402.
18. Enk AH, Angeloni VL, Udey MC, Katz SI. An essential role for Langerhans cell-derived IL-1β in the initiation of primary immune responses in the skin. J Immunol. 150:1993;3698-3704.
19. Cumberbatch M, Scott RC, Basketter DA, Scholes EW, Hilton J, Dearman RJ, Kimber I. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation. Toxicology. 77:1993;181-191.
20. Moodycliffe AM, Kimber I, Norval M. The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration. Immunology. 77:1992;394-399.
21. Jakob T, Udey MC. Regulation of E-cadherin-mediated adhesion in Langerhans cell-like dendritic cells by inflammatory mediators that mobilize Langerhans cells in vivo. of outstanding interest J Immunol. 160:1998;4067-4073 E-cadherin is a homophilic adhesion molecule expressed in the epidermis by both LCs and keratinocytes. It is believed that this molecule maintains the integrity of interaction between LCs and keratinocytes and that successful LC migration requires downregulated expression of E-cadherin. This paper reveals that IL-1β and TNF-α induce a rapid reduction in E-cadherin mRNA expression by LC-like cells.
22. Ma J, Wing J-H, Guo Y-J, Sy M-S, Bigby M. In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cell Immunol. 158:1994;389-399.
23. of outstanding interest Price AA, Cumberbatch M, Kimber I, Ager A. α6 integrins are required for Langerhans cell migration from the epidermis. of special interest J Exp Med. 186:1997;1725-1735 Evidence is presented here that the stimulation of LC migration, both in vitro and in vivo, is dependent upon the integrity of α6 integrin expression. Other references [21,22,24] define the role of other adhesion molecules in LC migration.
24. Weiss JM, Sleeman J, Renkl AC, Dittmar H, Termeer CC, Taxis S, Howells N, Hofmann M, Kohler G, Schopf E, et al. An essential role for CD44 variant isoforms in epidermal Langerhans cell and blood dendritic cell function. J Cell Biol. 137:1997;1137-1147.
25. Kobayashi Y. Langerhans cells produce type IV collagenase (MMP-9) following epicutaneous stimulation with haptens. Immunology. 90:1997;496-501.
26. Girolomoni G, Santantonio ML, Pastore S, Bergstresser PR, Gianetti A, Cruz PD Jr. Epidermal Langerhans cells are resistant to the permeabilizing effects of extracellular ATP: in vitro evidence supporting a protective role of membrane ATPase. J Invest Dermatol. 100:1993;282-287.
27. Perregauz D, Gabel CA. Interleukin-1β maturation and release in response to ATP and nigericin. J Biol Chem. 269:1994;15195-15203.
28. Griffiths RJ, Stam EJ, Downs JT, Otterness IG. ATP induces the release of IL-1 from LPS-primed cells in vivo. J Immunol. 154:1995;2821-2828.
29. Ferrari D, Chiozzi P, Falzoni S, Del Susino M, Melchiorri L, Baricordi OR, Di Virgilio F. Extracellular ATP triggers IL-1β release by activating the purinergic P2Z receptor of human macrophages. J Immunol. 159:1997;1451-1458.
30. Di Virgilio F. The P2Z purinoreceptor: an intriguing role in immunity, inflammation and cell death. Immunol Today. 16:1995;524-528.
31. Fantuzzi G, Ku G, Harding MW, Livingston DJ, Sipe JD, Kuida K, Flavell RA, Dinarello CA. Response to local inflammation of IL-1β-converting enzyme-deficient mice. J Immunol. 158:1997;1818-1824.
32. Dong M, Ladaviere L, Penin F, Deleage G, Baggetto LG. Secondary structure of p-glycoprotein investigated by circular dichroism and amino acid sequence analysis. Biochim Biophys Acta. 1371:1998;317-334.
33. Randolph GJ, Beaulieu S, Pope M, Sugawara I, Hoffman L, Steinman RM, Muller WA. A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. of outstanding interest Proc Natl Acad Sci USA. 95:1998;6924-6929 In this report, inhibition of MDR-1 - using either neutralizing antibodies or an antagonist - was found to reduce the migration of LCs from skin explants. The speculation is that MDR-1 may be required for the export of cytokines that are required for LC mobilization.
34. Barinaga M. Forging a path to cell death. Science. 273:1996;735-737.
35. Rothe M, Wong SC, Henzel WJ, Goeddel DV. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell. 78:1994;681-692.
36. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goedell DV. The TNFR2-TRAF signalling complex contains two novel proteins related to Baculoviral inhibitor of apoptosis proteins. Cell. 83:1995;1243-1252.
37. Chainy GBN, Singh S, Raju U, Aggarwal BB. Differential activation of the nuclear factor-κB by TNF muteins specific for the p60 and p80 TNF receptors. J Immunol. 157:1996;2410-2417.
38. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA, Pauli G. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur J Immunol. 25:1995;1943-1950.
39. Bjorck P, Banchereau J, Flores-Romo L. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells. of special interest Int Immunol. 9:1997;365-372 In this paper, evidence is presented that ligation of CD40 - during interaction with antigen-responsive T lymphocytes - protects DCs from Fas (CD95)-induced apoptosis, possibly via mechanisms related to the increased expression of bcl-2. This is one of several processes that facilitate the survival of LCs and the DCs into which they mature. See also references [37,38,40,41].
40. Tatsuta T, Cheng J, Mountz JD. Intracellular IL-1β is an inhibitor of Fas-mediated apoptosis. J Immunol. 157:1996;3949-3957.
41. Wong BR, Josien R, Lee SY, Sauter B, Li H-L, Steinman RM, Choi Y. TRANCE (tumour necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell specific survival factor. J Exp Med. 186:1997;2075-2080.
42. Osada A, Nakashima H, Furue M, Tamaki K. Up-regulation of CD44 expression by tumor necrosis factor-α is neutralized by interleukin-10 in Langerhans cells. J Invest Dermatol. 105:1995;124-127.
43. Buelens C, Willems F, Delvaux A, Pierard G, Delville J-P, Velu T, Goldman M. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol. 25:1995;2668-2672.
44. Morel A-S, Quaratino S, Douek DC, Londei M. Split activity of interleukin-10 on antigen capture and antigen presentation by human dendritic cells: definition of a maturative step. Eur J Immunol. 27:1997;26-34.
45. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of tolerance by IL-10-treated dendritic cells. J Immunol. 159:1997;4772-4780.
46. + T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens. Immunology. 89:1996;502-510.
47. Kalinski P, Hilkens CMU, Snijders A, Snijdewint FGM, Kapsenberg ML. IL-12 deficient dendritic cells, generated in the presence of prostoglandin E2, promote type 2 cytokine production in maturing human naive T helper cells. J Immunol. 159:1997;28-35.
48. + T lymphocyte selectivity.
49. Hope J, Cumberbatch M, Fielding I, Dearman RJ, Kimber I, Hopkins SJ. Identification of dendritic cells as a major source of interleukin-6 in draining lymph nodes following skin sensitization of mice. Immunology. 86:1995;441-447.
50. Cumberbatch M, Dearman RJ, Kimber I. Constitutive and inducible expression of interleukin 6 by Langerhans cells and lymph node dendritic cells. Immunology. 87:1996;513-518.
51. + T cells. J Exp Med. 185:1997;461-469.
52. Pfeiffer C, Stein J, Southwood S, Ketelaar H, Sette A, Bottomly K. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med. 181:1995;1569-1574.
53. + T cells. J Exp Med. 182:1995;1591-1596.
54. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J Exp Med. 81:1995;1081-1089.
55. + T lymphocytes were primed with either weak or strong TCR signals. Weak signals generated IL-4-producing Th2-type cells (requiring CD28 - B7 interactions), whereas stronger signals were associated with the generation of Th1-type cells. These data (together with other reports, references [52-54]) provide evidence for the influence of both the antigen dose and the affinity of interaction with the TCR on the quality of induced immune responses.